SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001214659-21-001278
Filing Date
2021-02-04
Accepted
2021-02-04 17:28:21
Documents
1
Group Members
MANGROVE PARTNERSNATHANIEL AUGUST

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 f24210sc13ga2.htm SC 13G/A 67703
  Complete submission text file 0001214659-21-001278.txt   69374
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82442 | Film No.: 21592391
SIC: 2834 Pharmaceutical Preparations

Mailing Address 645 MADISON AVE, 14 FLOOR NEW YORK NY 10022
Business Address MAPLES CORP. SVCS, PO BOX 309 UGLAND HOUSE, S. CHURCH STREET GEORGE TOWN E9 KY1-1104 2128979537
Mangrove Partners Master Fund, Ltd. (Filed by) CIK: 0001569227 (see all company filings)

IRS No.: 981083428 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A